Understanding these distinctions provides valuable insight into the pathophysiological basis of masticatory reflexes, facial pain, and peripheral neuropathic pain, and may aid in identifying novel therapeutic targets for sensory and orofacial disorders
This reduced thirst creates an opportunity to be proactive
Type 2 Diabetes (since 2009) Obesity treatment (since 2014) Cardiovascular outcomes and kidney trials ongoing Current research includes Alzheimers trials and other neurocognitive disorders | | Drug Examples: Liraglutide , Semaglutide | These GLP-1 receptor agonists are now being studied for their potential to cross the blood-brain barrier and exert neuroprotective effects, possibly mitigating oxidative stress and mitochondrial dysfunction associated with neurodegenerative diseases
Li R, Shan Y, Gao L, Wang X, Wang X, Wang F
Internationally , similar regulatory timelines apply